Henry C. Lai

Single- and double-strand DNA breaks in rat brain cells after acute exposure to radiofrequency electromagnetic radiation

We investigated the effects of acute (2-h) exposure to pulsed (2-micros pulse width, 500 pulses s(-1)) and continuous wave 2450-MHz radiofrequency electromagnetic radiation on DNA strand breaks in brain cells of rat. The spatial averaged power density of the radiation was 2mW/cm2, which produced a whole-body average-specific absorption rate of 1.2W/kg. Single- and double-strand DNA breaks in individual brain cells were measured at 4h post-exposure using a microgel electrophoresis assay. An increase in both types of DNA strand breaks was observed after exposure to either the pulsed or continuous-wave radiation, No significant difference was observed between the effects of the two forms of radiation. We speculate that these effects could result from a direct effect of radiofrequency electromagnetic energy on DNA molecules and/or impairment of DNA-damage repair mechanisms in brain cells. Our data further support the results of earlier in vitro and in vivo studies showing effects of radiofrequency electromagnetic radiation on DNA.

Development of artemisinin compounds for cancer treatment.

SummaryArtemisinin contains an endoperoxide moiety that can react with iron to form cytotoxic free radicals. Cancer cells contain significantly more intracellular free iron than normal cells and it has been shown that artemisinin and its analogs selectively cause apoptosis in many cancer cell lines. In addition, artemisinin compounds have been shown to have anti-angiogenic, anti-inflammatory, anti-metastasis, and growth inhibition effects. These properties make artemisinin compounds attractive cancer chemotherapeutic drug candidates. However, simple artemisinin analogs are less potent than traditional cancer chemotherapeutic agents and have short plasma half-lives, and would require high dosage and frequent administration to be effective for cancer treatment. More potent and target-selective artemisinin-compounds are being developed. These include artemisinin dimers and trimers, artemisinin hybrid compounds, and tagging of artemisinin compounds to molecules that are involved in the intracellular iron-delivery mechanism. These compounds are promising potent anticancer compounds that produce significantly less side effect than traditional chemotherapeutic agents.

Cytotoxicity of Ethanolic Extracts of Artemisia annua to Molt-4 Human Leukemia Cells

Although dihydroartemisinin (DHA) and other artemisinin derivatives have selective toxicity towards cancer cells, Artemisia annua (A. annua) extracts containing artemisinin have not been evaluated for their anticancer potential. Our main goal was to assess the anticancer effect of ethanolic leaf extracts of A. annua from Brazilian and Chinese origins (with DHA as a comparison) on normal and cancer cells. Leukocytes and leukemia (Molt-4) cells were counted at 0, 24, 48, and 72u2009hr after treatment with extracts having artemisinin concentrations of 0, 3.48, 6.96, and 13.92u2009µg/mL. Also, we assessed the antioxidant capacity of these extracts using the oxygen radical absorbance capacity (ORAC) test. Both extracts had high antioxidant capacity and toxicity towards Molt-4 cells. DHA was significantly more potent (pu2009<u20090.05) in killing Molt-4 cells than Brazilian extract at 48 and 72u2009hr and Chinese extract at 72 hr. In Molt-4 cells, LD₅₀ values for Brazilian and Chinese extracts were comparable at all time points and not significantly different from DHA at 24u2009hr. In leukocytes, DHA, Chinese extract, and Brazilian extract had LD₅₀ values of 760.42, 13.79, and 28.23u2009µg/mL of artemisinin, respectively, indicating a better safety index for the Brazilian extract compared to that of the Chinese extract at 24u2009hr. However, at 48 and 72u2009hr, the toxicity in leukocytes for any of the treatment groups was not significantly different. These experiments suggest that these extracts may have potential application in cancer treatment.

Medical applications of electromagnetic fields

In this article, we describe two possible applications of low-intensity non-ionizing electromagnetic fields (EMF) for the treatment of malaria and cancer, respectively. In malaria treatment, a low-intensity extremely-low frequency magnetic field can be used to induce vibration of hemozoin, a super-paramagnetic polymer particle, inside malaria parasites. This disturbance could cause free radical and mechanical damages leading to the death of the parasite. This concept has been tested in vitro on malaria parasites and found to be effective. This may provide a low cost effective treatment for malaria infection in humans. The rationale for cancer treatment using low-intensity EMF is based on two concepts that have been well established in the literature: (1) low-intensity non-thermal EMF enhances cytotoxic free radicals via the iron-mediated Fenton reaction; and (2) cancer cells have higher amounts of free iron, thus are more susceptible to the cytotoxic effects of EMF. Since normal cells contain minimal amount of free iron, the effect would be selectively targeting cancer cells. Thus, no adverse side effect would be expected as in traditional chemotherapy and radiation therapy. This concept has also been tested on human cancer cell and normal cells in vitro and proved to be feasible.

Effects of radiation from a radiofrequency identification (RFID) microchip on human cancer cells

Abstract Purpose Radiofrequency identification (RFID) microchips are used to remotely identify objects, e.g. an animal in which a chip is implanted. A passive RFID microchip absorbs energy from an external source and emits a radiofrequency identification signal which is then decoded by a detector. In the present study, we investigated the effect of the radiofrequency energy emitted by a RFID microchip on human cancer cells. Materials and methods Molt-4 leukemia, BT474 breast cancer, and HepG2 hepatic cancer cells were exposed in vitro to RFID microchip-emitted radiofrequency field for 1u2009h. Cells were counted before and after exposure. Effects of pretreatment with the spin-trap compound N-tert-butyl-alpha-phenylnitrone or the iron-chelator deferoxamine were also investigated. Results We found that the energy effectively killed/retarded the growth of the three different types of cancer cells, and the effect was blocked by the spin-trap compound or the iron-chelator, whereas an inactive microchip and energy from the external source had no significant effect on the cells. Conclusions Data of the present study suggest that radiofrequency field from the microchip affects cancer cells via the Fenton Reaction. Implantation of RFID microchips in tumors may provide a new method for cancer treatment.

Chapter 5:Methods for Freezing Blood Samples at −80 °C for DNA Damage Analysis in Human Leukocytes

Large-scale studies assessing DNA damage in the human population often have increased variability in results due to variations in handling and logistical restrictions of field work.1–2 In these studies, it is necessary to minimise DNA damage caused during collection, shipping, storage and analysis o...